Approval · Notice of Compliance 19476 · 2017
SPINRAZA: Notice of Compliance 19476
Issued June 29, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19476
- Date
- June 29, 2017
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPINRAZA | 02465663 | Marketed |
Medicinal ingredients
- NUSINERSEN SODIUM 2.4 MG per ML